Stay updated on LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding status banner was removed from the page, and the core study information remains unchanged.SummaryDifference0.4%

- Check49 days agoChange DetectedExternal health-information and government resource links (MedlinePlus Genetics, Graves' disease, MedlinePlus main site, Pulmonary Fibrosis page, HHS/NIH/NLM/NCBI/USA.gov) were removed from the page. This does not affect the study details, eligibility criteria, or contact information.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.4%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.2%

Stay in the know with updates to LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.